Longboard Pharmaceuticals Inc (LBPH)
$59.98 $0.00 (0.00%) 4:38 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$2.34B -
Day's Range
$59.98 - $59.98 -
Volume
836,393 -
52 Week Low / High
$4.37 - $60.03 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 1
- Strong Buy
- 1
- Buy
- 5
- Hold
- 0
- Sell
- 0
- Strong Sell
- $17.43
- Target Price
Company News
-
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? — Oct 14th, 2024
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share in cash. The transaction is valued at approximately $2.6 billion in equity value a...
-
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? — Oct 14th, 2024
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share in cash. The transaction is valued at approximately $2.6 billion in equity value a...
-
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? — Oct 14th, 2024
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share in cash. The transaction is valued at approximately $2.6 billion in equity value a...
-
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? — Oct 14th, 2024
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share in cash. The transaction is valued at approximately $2.6 billion in equity value a...
-
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? — Oct 14th, 2024
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share in cash. The transaction is valued at approximately $2.6 billion in equity value a...
-
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? — Oct 14th, 2024
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share in cash. The transaction is valued at approximately $2.6 billion in equity value a...
-
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? — Oct 14th, 2024
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share in cash. The transaction is valued at approximately $2.6 billion in equity value a...
-
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? — Oct 14th, 2024
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share in cash. The transaction is valued at approximately $2.6 billion in equity value a...
-
Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher — Jan 17th, 2024
You've no doubt heard a lot about the "Magnificent Seven" stocks. Each stock in this group -- Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta Platforms, and Tesla -- delivered gains of 48% or more in 2023. Nvidia more than tripled, while Meta came close to doing so. However, those perfor...
Similar Stocks
Portfolio
Comprised of 1 portfolios